The infectious disease Lassa fever can be fatal, and there is a lack of treatment options with proven efficacy. Researchers ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., May 15, 2026--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug ...
A new Phase I clinical trial provides proof of concept for a potential therapy for treatment-resistant cancers, particularly ...
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited – ...
A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...
An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a ...
EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the studies continue unchanged.
In a new study, researchers found that positive psychological well-being, which includes optimism, positive affect, and ...
Everyday Health on MSN
GLP-1 ‘Maintenance Dosing’ Works to Keep Pounds Off, New Trials Show
New research suggests that switching to a maintenance dose of GLP-1 medication could help lock in weight loss.
MAASTRICHT, the Netherlands—Mechanical thrombectomy improves functional outcomes for patients with acute ischemic strokes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results